Capital Markets Outlook for 2026

After the repricing cycle of 2023 and 2024, capital markets opened 2026 on steadier footing. Base rates have largely settled, spreads for investment-grade and upper-tier leveraged issuers have normalized from their peaks, and public equity investors are rewarding companies that can show a credible path to profitable growth rather than growth at any cost.

The shift is subtle but meaningful. Issuers who could previously raise on narrative alone are now being asked to demonstrate margin discipline, cash conversion, and a capital structure that leaves room for strategic investment. Sponsors with dry powder are still deploying, but investment committees are spending more time on entry multiples, add-on integration risk, and exit pathway clarity than they did eighteen months ago.

Corporate Issuers and Financing Structures

For corporate borrowers, the question is no longer whether capital is available, but how to structure it without giving up flexibility. Unitranche and senior secured facilities with covenant packages tailored to cyclical businesses remain in demand, as do preferred equity and structured common alongside traditional growth equity. Minority recapitalizations continue to attract founders and management teams who want partial liquidity without ceding operational control.

Lenders are also more deliberate about sector exposure. Business services and vertical software credits with recurring revenue profiles are clearing syndicates faster than cyclical industrials without clear visibility into 2026 earnings. Companies preparing for a financing event should expect more granular questions on customer concentration, churn, and working capital seasonality than in the prior cycle.

Private Equity Activity

Private equity sponsors remain active, though pacing has become more selective. Secondary processes and continuation vehicles are increasingly part of the toolkit, particularly for assets where near-term IPO or strategic sale timelines are uncertain. General partners are also spending more time with limited partners on portfolio construction and pacing, rather than assuming automatic follow-on commitments.

Add-on activity has held up better than platform acquisitions in several subsectors. Sponsors with existing healthcare services or software platforms are prioritizing tuck-ins that improve density, payer mix, or product breadth over new thesis bets. That dynamic favors sellers who can articulate a clear strategic fit with a defined buyer universe.

Sector Focus

The most active mandate flow we are seeing sits in business services, healthcare services, and vertical software, where recurring revenue, fragmentation, and operational improvement opportunities support durable sponsor interest. Industrials and energy transition adjacencies remain active for strategic acquirers seeking platform scale or technology access, though valuation gaps between buyers and sellers have widened in pockets of the market.

Healthcare services in particular continues to draw both strategic and financial buyer interest, with behavioral health, outpatient facilities, and physician services platforms among the more contested categories. Technology-enabled services businesses with strong retention metrics are also attracting crossover investor attention ahead of potential public market windows later in the year.

Cross-Border Capital Flows

Cross-border capital flows have re-accelerated after a period of caution. Middle Eastern and Asian institutional investors continue to deploy into North American and European assets, while U.S. and European limited partners are selectively increasing exposure to emerging manager strategies and sector specialists.

These processes are operationally heavier than domestic mandates. Currency hedging, regulatory disclosure, and shareholder communication requirements make timelines more dependent on advisors who can coordinate diligence and documentation across jurisdictions. Boards should budget additional preparation time when a transaction involves multiple regulatory regimes or shareholder constituencies.

Preparation and Process Discipline

For boards and management teams planning capital events in 2026, preparation timelines have lengthened. Investors expect audited-quality data rooms, clear capital allocation frameworks, and articulated downside cases. Companies that begin this work six to nine months ahead of a targeted launch are consistently achieving better outcomes on pricing, structure, and covenant flexibility than those entering suboptimal windows with incomplete materials.

That preparation extends to management presentations and investor Q&A. The best processes we have advised on in recent quarters shared a common trait: management teams who could speak credibly to unit economics, capital priorities, and competitive positioning without relying on slide decks to carry the conversation.

What We Are Watching

Liquidity remains available for quality credits and differentiated equity stories, but the era of broad-based easy capital has not returned. Success in 2026 will favor issuers and sponsors who combine realistic valuation expectations with disciplined process execution and direct access to the right institutional counterparties, not the widest possible outreach.

We will be publishing additional sector notes on healthcare services and vertical software in the coming weeks. For questions on capital raising, liability management, or strategic alternatives, our team can be reached through the contact page.